{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:12:00Z","timestamp":1770286320454,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,22]]},"DOI":"10.7759\/cureus.67502","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:33:35Z","timestamp":1724344415000},"source":"Crossref","is-referenced-by-count":1,"title":["CT-Guided Online Adaptive Radiotherapy Delivered via Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) for a Bulky Thoracic and Abdominal Mass in Oligometastatic Renal Cell Carcinoma"],"prefix":"10.7759","author":[{"given":"Ari A","family":"Kassardjian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colton","family":"Ladbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borna","family":"Maraghechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Rose","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savita","family":"Dandapani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Schwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Percy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(87)90283-5","article-title":"Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen renal cancer study group","volume":"13","author":"Kjaer M","year":"1987","unstructured":"Kjaer M, Frederiksen PL, Engelhom SA. Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen renal cancer study group. Int J Radiation Oncology Biol Phys. 1987, 13:665-72. 10.1016\/0360-3016(87)90283-5","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2019.06.002","article-title":"The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: a systematic review and meta-analysis","volume":"5","author":"Correa RJ","year":"2019","unstructured":"Correa RJ, Louie AV, Zaorsky NG, et al.. The emerging role of stereotactic ablative radiotherapy for primary renal cell carcinoma: a systematic review and meta-analysis. Eur Urol Focus. 2019, 5:958-69. 10.1016\/j.euf.2019.06.002","journal-title":"Eur Urol Focus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00020-2","article-title":"Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial","volume":"25","author":"Siva S","year":"2024","unstructured":"Siva S, Bressel M, Sidhom M, et al.. Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial. Lancet Oncol. 2024, 25:308-16. 10.1016\/S1470-2045(24)00020-2","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00528-3","article-title":"Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial","volume":"22","author":"Tang C","year":"2021","unstructured":"Tang C, Msaouel P, Hara K, et al.. Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial. Lancet Oncol. 2021, 22:1732-9. 10.1016\/S1470-2045(21)00528-3","journal-title":"Lancet Oncol"},{"key":"ref5","article-title":"Making on-line adaptive radiotherapy possible using artificial intelligence and machine learning for efficient daily re-planning","volume":"8","author":"Archambault Y","year":"2020","unstructured":"Archambault Y, Boylan C, Bullock D, et al.. Making on-line adaptive radiotherapy possible using artificial intelligence and machine learning for efficient daily re-planning. Med Physics Int. 2020, 8:77-86.","journal-title":"Med Physics Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.06.045","article-title":"Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life","volume":"108","author":"Jain S","year":"2013","unstructured":"Jain S, Poon I, Soliman H, et al.. Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life. Radiother Oncol. 2013, 108:320-5. 10.1016\/j.radonc.2013.06.045","journal-title":"Radiother Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.02.029","article-title":"Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): a phase 2 randomized trial","volume":"127","author":"Quon HC","year":"2018","unstructured":"Quon HC, Ong A, Cheung P, et al.. Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): a phase 2 randomized trial. Radiother Oncol. 2018, 127:206-12. 10.1016\/j.radonc.2018.02.029","journal-title":"Radiother Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.03.047","article-title":"Personalized ultrafracionated stereotactic adaptive radiotherapy (PULSAR) in preclinical models enhances single-agent immune checkpoint blockade","volume":"110","author":"Moore C","year":"2021","unstructured":"Moore C, Hsu CC, Chen WM, et al..  Personalized ultrafracionated stereotactic adaptive radiotherapy (PULSAR) in preclinical models enhances single-agent immune checkpoint blockade. Int J Radiat Oncol Biol Phys. 2021, 110:1306-16. 10.1016\/j.ijrobp.2021.03.047","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58684-6","article-title":"An AI-based approach for modeling the synergy between radiotherapy and immunotherapy","volume":"14","author":"Peng H","year":"2024","unstructured":"Peng H, Moore C, Zhang Y, Saha D, Jiang S, Timmerman R. An AI-based approach for modeling the synergy between radiotherapy and immunotherapy. Sci Rep. 2024, 14:8250. 10.1038\/s41598-024-58684-6","journal-title":"Sci Rep"},{"key":"ref10","unstructured":"Ethos, Varian. (2024). Accessed. May 20, 2024: https:\/\/www.varian.com\/products\/adaptive-therapy\/ethos."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2016.11.020","article-title":"Stereotactic body radiotherapy for large (> 5 cm) non-small cell lung cancer","volume":"18","author":"Peterson J","year":"2017","unstructured":"Peterson J, Niles C, Patel A, et al.. Stereotactic body radiotherapy for large (> 5 cm) non-small cell lung cancer. Clin Lung Cancer. 2017, 18:396-400. 10.1016\/j.cllc.2016.11.020","journal-title":"Clin Lung Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.01.045","article-title":"Stereotactic body radiation therapy for non-small cell lung cancer tumors greater than 5 cm: safety and efficacy","volume":"92","author":"Woody NM","year":"2015","unstructured":"Woody NM, Stephans KL, Marwaha G, Djemil T, Videtic GM. Stereotactic body radiation therapy for non-small cell lung cancer tumors greater than 5 cm: safety and efficacy. Int J Radiat Oncol Biol Phys. 2015, 92:325-31. 10.1016\/j.ijrobp.2015.01.045","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280113-ct-guided-online-adaptive-radiotherapy-delivered-via-personalized-ultrafractionated-stereotactic-adaptive-radiotherapy-pulsar-for-a-bulky-thoracic-and-abdominal-mass-in-oligometastatic-renal-cell-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:33:40Z","timestamp":1724344420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280113-ct-guided-online-adaptive-radiotherapy-delivered-via-personalized-ultrafractionated-stereotactic-adaptive-radiotherapy-pulsar-for-a-bulky-thoracic-and-abdominal-mass-in-oligometastatic-renal-cell-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.67502","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}